MTF Biologics and Kolosis BIO Launch the Latest Addition to the DBX Family: DBX Fiber®
EDISON, N.J. & SALT LAKE CITY–(BUSINESS WIRE)–MTF Biologics, a global
Menu
Leverage Established GPO and IDN Agreements through MTF.
The Biggest Technologies in biologics delivered to you.
A 100% allogenic extracellular matrix from Kolosis, designed to cover and protect in the natural wound healing environment.
MTF’s proprietary aseptic processing ensures preservation of key biological matrices and vital matrix proteins.1
For decades, DBX has been a trusted name in DBM, earning its reputation through years of proven performance in both preclinical animal models and in clinical studies.1
A 100% demineralized cortical bone allograft engineered to address the complex demands of sternal fusion.
Allograft membrane designed to help with optimizing surgical outcomes and reducing complications in poor healing patients.
EDISON, N.J. & SALT LAKE CITY–(BUSINESS WIRE)–MTF Biologics, a global
Salt Lake City, Utah — Kolosis®, the industry’s leading pure-play
The Kolosis team will be attending the 2026 Spine Summit